vs

Side-by-side financial comparison of APTARGROUP, INC. (ATR) and Invesco (IVZ). Click either name above to swap in a different company.

Invesco is the larger business by last-quarter revenue ($1.7B vs $982.9M, roughly 1.7× APTARGROUP, INC.). APTARGROUP, INC. runs the higher net margin — 7.4% vs -58.9%, a 66.3% gap on every dollar of revenue. On growth, APTARGROUP, INC. posted the faster year-over-year revenue change (10.8% vs 6.2%). Invesco produced more free cash flow last quarter ($432.2M vs $53.3M). Over the past eight quarters, Invesco's revenue compounded faster (7.1% CAGR vs 3.9%).

AptarGroup, Inc., also known as Aptar, is a United States–based global manufacturer of consumer dispensing packaging and drug delivery devices. The group has manufacturing operations in 18 countries.

Invesco Ltd. is an American independent investment management company headquartered in Atlanta, Georgia, with branch offices in 20 countries. Its common stock is a constituent of the S&P 500 and trades on the New York Stock Exchange. Invesco operates under the Invesco, Invesco Perpetual, and Powershares brand names.

ATR vs IVZ — Head-to-Head

Bigger by revenue
IVZ
IVZ
1.7× larger
IVZ
$1.7B
$982.9M
ATR
Growing faster (revenue YoY)
ATR
ATR
+4.6% gap
ATR
10.8%
6.2%
IVZ
Higher net margin
ATR
ATR
66.3% more per $
ATR
7.4%
-58.9%
IVZ
More free cash flow
IVZ
IVZ
$378.9M more FCF
IVZ
$432.2M
$53.3M
ATR
Faster 2-yr revenue CAGR
IVZ
IVZ
Annualised
IVZ
7.1%
3.9%
ATR

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
ATR
ATR
IVZ
IVZ
Revenue
$982.9M
$1.7B
Net Profit
$72.8M
$-995.9M
Gross Margin
Operating Margin
10.9%
-86.2%
Net Margin
7.4%
-58.9%
Revenue YoY
10.8%
6.2%
Net Profit YoY
-7.5%
-575.8%
EPS (diluted)
$1.12
$-2.61

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ATR
ATR
IVZ
IVZ
Q1 26
$982.9M
Q4 25
$962.7M
$1.7B
Q3 25
$961.1M
$1.6B
Q2 25
$966.0M
$1.5B
Q1 25
$887.3M
$1.5B
Q4 24
$848.1M
$1.6B
Q3 24
$909.3M
$1.5B
Q2 24
$910.1M
$1.5B
Net Profit
ATR
ATR
IVZ
IVZ
Q1 26
$72.8M
Q4 25
$74.3M
$-995.9M
Q3 25
$127.9M
$356.4M
Q2 25
$111.7M
$197.4M
Q1 25
$78.8M
$171.1M
Q4 24
$100.9M
$209.3M
Q3 24
$100.0M
$55.0M
Q2 24
$90.5M
$132.2M
Operating Margin
ATR
ATR
IVZ
IVZ
Q1 26
10.9%
Q4 25
11.0%
-86.2%
Q3 25
14.2%
16.5%
Q2 25
14.9%
14.1%
Q1 25
12.8%
18.1%
Q4 24
14.2%
19.6%
Q3 24
15.2%
6.6%
Q2 24
13.8%
13.9%
Net Margin
ATR
ATR
IVZ
IVZ
Q1 26
7.4%
Q4 25
7.7%
-58.9%
Q3 25
13.3%
21.7%
Q2 25
11.6%
13.0%
Q1 25
8.9%
11.2%
Q4 24
11.9%
13.1%
Q3 24
11.0%
3.6%
Q2 24
9.9%
8.9%
EPS (diluted)
ATR
ATR
IVZ
IVZ
Q1 26
$1.12
Q4 25
$1.13
$-2.61
Q3 25
$1.92
$0.66
Q2 25
$1.67
$-0.03
Q1 25
$1.17
$0.38
Q4 24
$1.48
$0.46
Q3 24
$1.48
$0.12
Q2 24
$1.34
$0.29

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ATR
ATR
IVZ
IVZ
Cash + ST InvestmentsLiquidity on hand
$229.5M
$1.0B
Total DebtLower is stronger
$1.8B
Stockholders' EquityBook value
$2.6B
$12.2B
Total Assets
$5.1B
$27.1B
Debt / EquityLower = less leverage
0.15×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ATR
ATR
IVZ
IVZ
Q1 26
$229.5M
Q4 25
$409.5M
$1.0B
Q3 25
$264.8M
$973.1M
Q2 25
$169.8M
$922.7M
Q1 25
$136.8M
$821.7M
Q4 24
$226.2M
$986.5M
Q3 24
$327.9M
$1.0B
Q2 24
$223.9M
$878.5M
Total Debt
ATR
ATR
IVZ
IVZ
Q1 26
Q4 25
$1.1B
$1.8B
Q3 25
$546.0M
$1.6B
Q2 25
$535.1M
$1.9B
Q1 25
$561.2M
$964.8M
Q4 24
$688.1M
$890.6M
Q3 24
$822.7M
$890.3M
Q2 24
$681.5M
$890.1M
Stockholders' Equity
ATR
ATR
IVZ
IVZ
Q1 26
$2.6B
Q4 25
$2.7B
$12.2B
Q3 25
$2.8B
$14.0B
Q2 25
$2.7B
$13.9B
Q1 25
$2.5B
$14.7B
Q4 24
$2.5B
$14.6B
Q3 24
$2.5B
$14.8B
Q2 24
$2.4B
$14.6B
Total Assets
ATR
ATR
IVZ
IVZ
Q1 26
$5.1B
Q4 25
$5.3B
$27.1B
Q3 25
$5.1B
$28.4B
Q2 25
$4.9B
$28.5B
Q1 25
$4.5B
$28.1B
Q4 24
$4.4B
$27.0B
Q3 24
$4.6B
$27.5B
Q2 24
$4.5B
$27.2B
Debt / Equity
ATR
ATR
IVZ
IVZ
Q1 26
Q4 25
0.43×
0.15×
Q3 25
0.20×
0.12×
Q2 25
0.20×
0.14×
Q1 25
0.22×
0.07×
Q4 24
0.28×
0.06×
Q3 24
0.32×
0.06×
Q2 24
0.28×
0.06×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ATR
ATR
IVZ
IVZ
Operating Cash FlowLast quarter
$455.8M
Free Cash FlowOCF − Capex
$53.3M
$432.2M
FCF MarginFCF / Revenue
5.4%
25.5%
Capex IntensityCapex / Revenue
6.7%
1.4%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$327.0M
$1.4B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ATR
ATR
IVZ
IVZ
Q1 26
Q4 25
$183.7M
$455.8M
Q3 25
$177.6M
$606.2M
Q2 25
$126.0M
$547.9M
Q1 25
$82.7M
$-84.6M
Q4 24
$178.2M
$316.9M
Q3 24
$229.3M
$438.4M
Q2 24
$143.6M
$489.1M
Free Cash Flow
ATR
ATR
IVZ
IVZ
Q1 26
$53.3M
Q4 25
$96.9M
$432.2M
Q3 25
$114.3M
$586.4M
Q2 25
$62.5M
$530.4M
Q1 25
$25.9M
$-108.0M
Q4 24
$112.2M
$309.9M
Q3 24
$162.7M
$410.0M
Q2 24
$75.4M
$462.4M
FCF Margin
ATR
ATR
IVZ
IVZ
Q1 26
5.4%
Q4 25
10.1%
25.5%
Q3 25
11.9%
35.7%
Q2 25
6.5%
35.0%
Q1 25
2.9%
-7.1%
Q4 24
13.2%
19.5%
Q3 24
17.9%
27.1%
Q2 24
8.3%
31.2%
Capex Intensity
ATR
ATR
IVZ
IVZ
Q1 26
6.7%
Q4 25
9.0%
1.4%
Q3 25
6.6%
1.2%
Q2 25
6.6%
1.2%
Q1 25
6.4%
1.5%
Q4 24
7.8%
0.4%
Q3 24
7.3%
1.9%
Q2 24
7.5%
1.8%
Cash Conversion
ATR
ATR
IVZ
IVZ
Q1 26
Q4 25
2.47×
Q3 25
1.39×
1.70×
Q2 25
1.13×
2.78×
Q1 25
1.05×
-0.49×
Q4 24
1.77×
1.51×
Q3 24
2.29×
7.97×
Q2 24
1.59×
3.70×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ATR
ATR

Segment breakdown not available.

IVZ
IVZ

Investment Advice$1.2B73%
Distribution And Shareholder Service$382.7M23%
Financial Service Other$51.0M3%
Investment Performance$28.9M2%

Related Comparisons